Commentary · 21 Feb 2026
Conference abstractPublished 18 Jul 2018
Burden of gynecological cancer and inequity in cancer care in developing world
Liaquat National Hospital & Medical College, Pakistan
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The gynecological cancer burden in developing countries is huge. Approximately 1:4 of all cancers in women in developing countries is a gynaecological cancer. According to international agency for research on cervical cancer (IARC) 2008, 53% of the 12.7 million new cases of cancer and 63% of all the 7.6 million deaths occurred in developing countries. Three decades earlier, developing countries accounted only for 15% of global cancer burden. A report based on IARC / GLOBOCAN 2002 world cancer statistics estimated that by the year 2020, about 10.25 million new cases of cancer would be diagnosed in developing countries. Ovarian cancer is the second most common cancer, accounting for 18.8% of all gynaecological cancers in developing countries. Vaginal cancer constitutes less than 2% worldwide, with 68% being in developing countries. Vulval cancer constitutes 3% of gynaecological malignancies in the developed world vs. 41.4% in developing countries. Choriocarcinoma represents 0.6% of gynaecological malignancies worldwide, with 96.4% occurring in developing countries, highest incidence being in South East Asia. There is vast disparity in health care for gynaecological cancers worldwide. Developing countries have more infectious morbidity with limited resources, lack of tumour registries, poor infrastructure of health departments, limited diagnostic and treatment facilities, and lack of computerized databases to facilitate follow-up. Only 5% of the worldâ??s total resources for cancer control reach the developing world. It is the responsibility of international health organizations, as well as resource rich countries to provide capital resources, mentorship & training to aid developing countries to control cancer burden.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Haleema A Hashmi”
